Jean Li Yan

Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia

Julio A. Ramírez, Nathalie Dartois, Hassan Gandjini et al. · Antimicrobial Agents and Chemotherapy · 2013 · 235 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis

Laszlo Lauf, Zsófia Ozsvár, J Regöly-Mérei et al. · Diagnostic Microbiology and Infectious Disease · 2013 · 95 citations · Full text

Health Professions, Infectious Diseases, Pharmacotherapy +17

Pharmacokinetics and Safety Profile of Tigecycline in Children Aged 8 to 11 Years With Selected Serious Infections: A Multicenter, Open-Label, Ascending-Dose Study

J. Purdy, Sylvie Jouve, Jean Li Yan et al. · Clinical Therapeutics · 2012 · 56 citations

Medicine, Pediatrics, Pharmacokinetics +15

Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study

Bassem Hamandi, Christine Fegbeutel, Fernanda P. Silveira et al. · American Journal of Transplantation · 2017 · 42 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Ceftaroline fosamil doses and breakpoints for <i>Staphylococcus aureus</i> in complicated skin and soft tissue infections

Shampa Das, Jianguo Li, Joseph P. Iaconis et al. · Journal of Antimicrobial Chemotherapy · 2018 · 37 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17